Dashboard
Manage Tickers

PRPH ProPhase Labs, Inc.

Nasdaq prophaselabs.com


$ 0.38 $ 0.01 (3.23 %)    

Thursday, 30-Oct-2025 12:35:42 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 630.83 $ -1.23 (-0.19 %)
DIA $ 478.05 $ 3.87 (0.82 %)
SPY $ 684.39 $ 0.55 (0.08 %)
TLT $ 90.69 $ 0.29 (0.32 %)
GLD $ 368.06 $ 2.97 (0.81 %)
$ 0.3774
$ 0.37
$ 0.38 x 2,200
$ 0.38 x 1,500
$ 0.36 - $ 0.38
$ 0.22 - $ 2.39
1,791,099
na
15.68M
$ 1.09
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2025 06-30-2025 10-Q
2 05-20-2025 03-31-2025 10-Q
3 03-31-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-10-2024 03-31-2024 10-Q
7 03-28-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-11-2023 06-30-2023 10-Q
10 05-12-2023 03-31-2023 10-Q
11 03-29-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-12-2022 06-30-2022 10-Q
14 05-13-2022 03-31-2022 10-Q
15 03-31-2022 12-31-2021 10-K
16 11-12-2021 09-30-2021 10-Q
17 08-13-2021 06-30-2021 10-Q
18 05-14-2021 03-31-2021 10-Q
19 03-31-2021 12-31-2020 10-K
20 11-19-2020 09-30-2020 10-Q
21 08-11-2020 06-30-2020 10-Q
22 05-12-2020 03-31-2020 10-Q
23 03-26-2020 12-31-2019 10-K
24 11-12-2019 09-30-2019 10-Q
25 08-12-2019 06-30-2019 10-Q
26 05-14-2019 03-31-2019 10-Q
27 03-26-2019 12-31-2018 10-K
28 11-14-2018 09-30-2018 10-Q
29 08-20-2018 06-30-2018 10-Q
30 05-15-2018 03-31-2018 10-Q
31 03-28-2018 12-31-2017 10-K
32 11-13-2017 09-30-2017 10-Q
33 08-11-2017 06-30-2017 10-Q
34 05-15-2017 03-31-2017 10-Q
35 02-24-2017 12-31-2016 10-K
36 11-15-2016 09-30-2016 10-Q
37 08-11-2016 06-30-2016 10-Q
38 05-13-2016 03-31-2016 10-Q
39 03-29-2016 12-31-2015 10-K
40 11-13-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

prophase-labs-announces-publication-of-peer-reviewed-study-in-clinical-and-translational-gastroenterology-conducted-with-the-mayo-clinic-showing-100-sensitivity-and-strong-predictive-accuracy-for-progression-to-esophageal-cancer
Prophase Labs Announces Publication Of Pee...
10/29/2025 12:34:27

Peer-Reviewed Study Conducted in Collaboration with Mayo Clinic Demonstrates 100% Sensitivity and Strong Predictive Power for E...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/22/2025 17:06:27

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/22/2025 12:09:33

prophase-labs-announces-study-validating-its-be-smart-esophageal-test-has-been-accepted-for-publication-in-clinical-gastroenterology-and-hepatology
ProPhase Labs Announces Study Validating I...
10/22/2025 11:31:42

prophase-labs-entered-into-sales-agreement-with-westpark-capital-relating-to-shares-of-common-stock-offered-by-prospectus-supplement--may-offer-and-sell-shares-of-common-stock-from-time-to-time-up-to-43m
ProPhase Labs Entered Into Sales Agreement...
10/15/2025 21:31:12

https://www.sec.gov/Archives/edgar/data/868278/000149315225018187/form424b5.htm

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
10/03/2025 21:05:59

three-of-prophase-labs-covid-19-testing-laboratories-filed-for-chapter-ii
Three Of ProPhase Labs' COVID-19 Testing L...
09/23/2025 12:08:36

prophase-enters-agreement-relating-to-potential-advisory-services-as-management-explores-crypto-treasury-strategy
ProPhase Enters Agreement Relating To Pote...
09/22/2025 12:15:09

prophase-labs-says-on-sept-12-entered-strategic-advisory-and-private-placement-agreement-with-thinkequity-pursuant-to-which-thinkequity-will-serve-as-advisor-in-connection-with-digital-asset-strategy-and-proposed-private-placement-of-6m-of-cos-securities
ProPhase Labs Says On Sept. 12 Entered Str...
09/18/2025 20:21:07

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
09/12/2025 17:06:17

prophase-labs-shareholders-approve-strategic-expansion-including-increase-in-authorized-shares-to-1b
ProPhase Labs Shareholders Approve Strateg...
09/12/2025 12:12:20

ProPhase Labs Stockholders Deliver Strong Mandate at Special MeetingUNIONDALE, NY, Sept. 12, 2025 (GLOBE NEWSWIRE) -- ProPhase ...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/11/2025 21:06:02

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/09/2025 17:06:26

prophase-labs-q2-eps-011-beats-015-estimate-sales-1247m-may-not-be-comparable-to-3550m-estimate
ProPhase Labs Q2 EPS $(0.11) Beats $(0.15)...
08/13/2025 12:04:26

The Company did not generate any revenues from diagnostic services for the three months ended June 30, 2025 and 2024, respectiv...

Core News & Articles
Earnings Scheduled For August 13, 2025
08/13/2025 08:32:30

earnings-preview-for-prophase-labs
Earnings Preview For ProPhase Labs
08/12/2025 20:02:27

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/12/2025 17:07:02

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/12/2025 12:08:34

prophase-labs-announces-uspto-issued-patent-for-the-companys-biomarker-based-systems-and-methods-to-assess-progression-risk-in-barretts-esophagus-and-esophageal-adenocarcinoma
ProPhase Labs Announces USPTO Issued Paten...
08/12/2025 12:04:43

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
08/01/2025 21:06:34

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION